Literature DB >> 2295837

Inhibition of autoimmune disease in a murine model of systemic lupus erythematosus induced by exposure to syngeneic photoinactivated lymphocytes.

C L Berger1, M Perez, L Laroche, R Edelson.   

Abstract

MRL/l mice develop progressive, virulent autoimmune disease that has many of the features of systemic lupus erythematosus. Prophylactic treatment of MRL/l mice with syngeneic photoinactivated autoimmune splenocytes improves survival and inhibits the fulminant hyperproliferation of abnormal T cells and the production of high titer anti-DNA antibody invariably found in untreated mice. The proliferation of Thy 1+ splenic T cells was significantly decreased, and prolonged retention of the response to T-cell mitogen was found in treated mice. Treatment with unmodified cells induced a partial inhibition of disease features which did not prolong survival rates. These results suggest that phototherapy potentiates a normal immunoregulatory process which enables suppression of the development of abnormal cell populations in young MRL/l mice with relatively intact immune systems.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2295837     DOI: 10.1111/1523-1747.ep12873349

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  10 in total

1.  Photopheresis at onset of type 1 diabetes: a randomised, double blind, placebo controlled trial.

Authors:  J Ludvigsson; U Samuelsson; J Ernerudh; C Johansson; L Stenhammar; G Berlin
Journal:  Arch Dis Child       Date:  2001-08       Impact factor: 3.791

2.  Rapid generation of maturationally synchronized human dendritic cells: contribution to the clinical efficacy of extracorporeal photochemotherapy.

Authors:  Carole Berger; Kristin Hoffmann; Juan G Vasquez; Shrikant Mane; Julia Lewis; Renata Filler; Aiping Lin; Hongyu Zhao; Tyler Durazzo; Abigail Baird; William Lin; Francine Foss; Inger Christensen; Michael Girardi; Robert Tigelaar; Richard Edelson
Journal:  Blood       Date:  2010-08-18       Impact factor: 22.113

3.  Extracorporeal photochemotherapy for the treatment of lupus erythematosus: preliminary observations.

Authors:  R M Knobler
Journal:  Springer Semin Immunopathol       Date:  1994

Review 4.  Systemic lupus erythematosus--disease management.

Authors:  M F Gourley
Journal:  Springer Semin Immunopathol       Date:  1994

5.  Phototherapy--T cell vaccination by any other name?

Authors:  G S Panayi
Journal:  Clin Exp Immunol       Date:  1994-03       Impact factor: 4.330

6.  Treatment of severe atopic dermatitis with extracorporeal photopheresis.

Authors:  B Prinz; F Nachbar; G Plewig
Journal:  Arch Dermatol Res       Date:  1994       Impact factor: 3.017

7.  Photodynamic therapy; a comparison with other immunomodulatory treatments of adjuvant-enhanced arthritis in MRL-lpr mice.

Authors:  L G Ratkay; R K Chowdhary; H C Neyndorff; J Tonzetich; J D Waterfield; J G Levy
Journal:  Clin Exp Immunol       Date:  1994-03       Impact factor: 4.330

8.  CD11c+ dendritic cells mediate antigen-specific suppression in extracorporeal photopheresis.

Authors:  H Hackstein; A Kalina; T Jakob; G Bein; B Dorn; I S Keil; N Baal; G Michel; C Brendel; A Neubauer
Journal:  Clin Exp Immunol       Date:  2020-11-08       Impact factor: 4.330

Review 9.  Photopheresis: a new therapeutic concept.

Authors:  R L Edelson
Journal:  Yale J Biol Med       Date:  1989 Nov-Dec

Review 10.  Experimental murine and primate models for dissection of the immunosuppressive potential of photochemotherapy in autoimmune disease and transplantation.

Authors:  C L Berger
Journal:  Yale J Biol Med       Date:  1989 Nov-Dec
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.